top of page
Clearview Wealth Ltd

Clearview Wealth Ltd – Fund Manager Investment Commentary & Insights

ASX:CVW

Life & Health Insurance

Fund Manager Summary on Clearview Wealth Ltd (ASX:CVW)

Clearview Wealth Ltd (ASX: CVW) has transitioned from a legacy life insurer to a digitally enabled player with a robust operational framework following its exit from wealth management and the rollout of its cloud-based insurance platform. Recent commentary emphasizes strong financial momentum, with FY26 NPAT guidance between $42 million and $47 million, alongside a projected 40% increase in NPAT, making the forward P/E attractive at 7.8x. Fund managers perceive Clearview as a compelling growth story, enhanced by a significant share buyback initiative and a dual focus on margin preservation through targeted price hikes amidst an 8% market growth. However, risks include claims volatility, potential tech migration issues, and distribution channel sensitivities due to regulatory changes. Overall, managers suggest that the stock is undervalued, reflecting a substantial discount to intrinsic value, with market sentiment likely to shift as operational efficiencies materialize.

Commentary From The Managers

There are 8 insights from 4 fund managers regarding their investment in Clearview Wealth Ltd (ASX:CVW) available on Thesis Tracker.

Unlock Updates With ThesisTracker Pro

Don’t let information asymmetry undermine your investment returns. Join other engaged investors on ThesisTracker Pro.

Updates are made available to members within 12 hours of being released. ​The completeness, accuracy or current status of the investments referenced are not guaranteed. 

Commentary From The Managers

Tamim Funds Management

11 Feb 2026

$0.53

Summary

  • Tamim Funds Management believes ClearView represents compelling value and continues to hold, noting that the company's strong operational momentum and embedded value suggest the current Zurich takeover offer may undervalue the business.
  • Zurich has proposed to acquire ClearView via a scheme of arrangement at 65 cents per share in cash, plus a potential fully franked dividend of up to 5 cents, implying ~2.14 cents in additional franking credits.
  • ClearView's 1H FY26 results were strong: new business sales +29% to $21.0m, in-force premiums +13% to $436m, gross premium revenue +13% to $215.6m, and underlying NPAT +77% to $22.1m.
  • The gross claims loss ratio of 51% remains stable, consistent with the long-term average of ~52%, supporting earnings predictability as the policy base grows.
  • ClearView's embedded value is estimated at 78–88 cents per share, materially above the current offer of 65 cents, suggesting the bid captures the business at a discount to its long-term economic value.
  • Tamim believes a competing bid of 70–75 cents per share could be financially justified, and monitors whether a rival offer emerges before the expected scheme meeting in mid-August 2026.
  • A cloud-based technology transformation is underway, including a new digital front-end platform due in 2H FY26, which is expected to reduce costs and improve long-term competitiveness.

Tamim Funds Management

31 Oct 2025

$0.60

Summary

  • Clearview Wealth (ASX: CVW) reported a bullish Q1 FY26 update with 13% growth in new business and in-force premiums of $425.3m.
  • Claims are within expectations, with last year’s dip considered a one-off.
  • The company prioritizes margin over volume in an 8% growing market.
  • Implemented targeted price increases of 20% for TPD and 11% for income protection.
  • Focus on managing legacy TPD exposure and enhancing retention through customer transitions to newer products.
  • A major tech upgrade to Oracle and Salesforce is set to complete by Christmas, promising cost savings and improved user experience.
  • This upgrade is expected to help accelerate growth in other products like retirement and direct channels.
  • The board favors buybacks over dividends, maintaining a 40–60% payout ratio.
  • Tamim Funds Management has provided feedback to reinstate dividends as soon as possible.
  • Trading on 8.5x PE while growing earnings at strong double digits indicates significant upside potential in the next 6-9 months.
  • Management will announce a new medium-term aspirational target at the August results, viewed as a major catalyst to re-rate the stock to 90 cents or higher.

Tamim Funds Management

11 Sept 2025

$0.57

Summary

  • Tamim Funds Management highlights ClearView Wealth (ASX: CVW) as a misunderstood opportunity in the life insurance sector.
  • ClearView has transitioned from a legacy business to a nimble fintech, marked by the launch of its cloud-based insurance platform.
  • FY25 results indicate a turning point with strong second-half performance despite an overall decline in full-year NPAT.
  • Key metrics include: $22.5 million in 2H25 NPAT (up 12% YoY), 10% increase in in-force premiums, and 5% rise in embedded value.
  • ClearView's buyback program has repurchased 11.4 million shares, indicating the board's belief in the company's undervaluation.
  • FY26 guidance is optimistic, with projected gross premium income of $435–$440 million and underlying NPAT of $42–$47 million.
  • The company has completed its tech migration, enabling faster policy issuance and lower costs, enhancing its competitive edge.
  • ClearView is viewed as a potential takeover target due to its clean balance sheet and modernized systems.
  • Risks include claims volatility and distribution reliance on IFA channels, but the risks appear asymmetric, favoring upside potential.
  • At a current share price of ~56 cents, ClearView trades at a low valuation relative to its growth prospects, with a target range of 80–90 cents suggested.
  • Tamim Funds Management believes ClearView is at an inflection point with significant upside potential in a quality-starved market.

Balmoral Investors

31 Aug 2025

$0.53

Summary

  • Balmoral Investors continues to hold interest in ClearView Wealth Limited as it is an independent pure play life insurer focused on helping Australians protect and build their wealth.
  • ClearView offers a range of life insurance products, including term life, total and permanent disability, critical illness benefits, and income protection.
  • In the last two years, ClearView has simplified its business by exiting non-strategic partnerships in Wealth Management and financial planning.
  • FY25 experienced a split performance with 1H25 facing high claims levels, which reversed in 2H25.
  • ClearView has a history of gaining market share, with new business written exceeding the company’s market share, leading to faster growth of the in-force book.
  • Investment in cloud-based infrastructure and technology is enabling scalable growth, with migration to a single core insurance platform expected to reduce complexity.
  • Recent enhancements to front-end systems have improved efficiency and reduced processing costs.
  • Balmoral Investors anticipates further operating leverage to become evident in FY26 and beyond.
  • Management has provided guidance for FY26, projecting an underlying NPAT of $42m - $47m, which represents a +38% increase at the midpoint compared to FY25.

Tamim Funds Management

31 Aug 2025

$0.53

Summary

  • ClearView Wealth (ASX: CVW) is transitioning from a legacy life insurance business to a digitally native player.
  • The successful rollout of a cloud-based insurance platform marks a significant shift towards scaling operations.
  • Strong second-half results include $22.5 million in life insurance underlying NPAT (up 12% YoY) and in-force premiums up 10% to $412.9 million.
  • Despite a 5% decline in full-year NPAT, operational improvements indicate a stable foundation for growth.
  • Capital management is a focus, with 11.4 million shares repurchased as part of a buyback program.
  • ClearView is trading at a forward P/E of 7.8x, suggesting shares may be undervalued.
  • FY26 guidance indicates gross premium income of $435–$440 million and underlying NPAT of $42–$47 million.
  • Digital transformation enables faster policy issuance and lower costs, enhancing competitive positioning.
  • Management demonstrates a founder mentality with a focus on operational simplicity and shareholder returns.
  • ClearView remains a potential takeover target due to its clean balance sheet and scalable platform.
  • Risks include claims volatility and distribution challenges, but the outlook appears promising.
  • Current pricing suggests a material upside with a target range of 80–90 cents per share.
  • ClearView is evolving into a capital-efficient platform business with strong earnings momentum and strategic optionality.

Tamim Funds Management

3 Apr 2025

$0.48

Summary

  • Tamim Funds Management identifies ClearView as a deep value opportunity in the life insurance sector.
  • The company has shown resilience, recovering from a Q1 FY25 claims spike with a significant NPAT increase in Q2 from $4.2 million to $11.0 million.
  • Management has opted for a 10% share buyback instead of dividends, addressing the disconnect between intrinsic value and market price.
  • Net assets are valued at 55.1 cents per share, with embedded value at 94 cents, while the stock trades around 45-50 cents, indicating a 50%+ discount to fair value.
  • Premium growth is robust, increasing 8% to $191.4 million, maintaining a 10.6% market share in new life insurance business.
  • Cost management and retention strategies are in place to restore margins.
  • Tamim Funds Management views this as a multi-year compounding story, with FY25 NPAT estimated at $32.5 million and FY26 forecasts at $46.8 million.
  • If management executes effectively, the stock could potentially re-rate to 70-80 cents, suggesting 50-80% upside in the next 12 months.
  • With a forecast P/E of 6.2x FY26 earnings, there is a substantial margin of safety.

QVG Capital

30 Nov 2024

$0.33

Summary

  • QVG Capital notes a significant and unexpected claims impact for Clearview Wealth Ltd in their September quarter.
  • QVG Capital acknowledges that the full impact of claims may not yet be realized.
  • QVG Capital believes the worst is behind Clearview Wealth Ltd.
  • QVG Capital plans to exercise patience due to the compelling valuation of the company.

Firetrail Investments

30 Nov 2024

$0.33

Summary

  • Firetrail Investments notes that Clearview Wealth Ltd has recently underperformed due to a material increase in claims in its legacy Life Solutions portfolio.
  • The increase in claims specifically affected Total and Permanent Disability (TPD) and Income Protection products, resulting in a $6.2m after-tax claims loss.
  • Despite this setback, claims have normalized as of October, and management does not perceive this as a long-term issue.
  • Clearview is actively addressing the situation through repricing, claims management, and client retention strategies.
  • Firetrail Investments continues to hold its position in Clearview Wealth Ltd based on the belief in the company's strategic response to current challenges.

The completeness, accuracy or current status of the investments referenced are not guaranteed. 

Investment Ideas Scanner

Loading...

Frequently Asked Questions

Who is investing in Clearview Wealth Ltd (ASX:CVW)?

Fund managers including Firetrail Investments, QVG Capital, Tamim Funds Management and Balmoral Investors have invested in Clearview Wealth Ltd (ASX:CVW).

Why do fund managers invest in Clearview Wealth Ltd?

Fund managers are increasingly investing in Clearview Wealth Ltd due to its significant transformation into a digitally enabled life insurer. The company's strategic exit from wealth management and the successful launch of a cloud-based insurance platform enhance operational efficiency, improve margins, and facilitate faster customer service. With a modest market cap and strong earnings growth potential, as evidenced by its recent performance and guidance, Clearview's attractive valuation at a low P/E ratio and ongoing share buyback program further appeal to investors seeking undervalued assets in the life insurance sector.

What happened to Clearview Wealth Ltd (ASX:CVW)?

Fund managers, including Tamim Funds Management, are investing in Clearview Wealth Ltd (ASX: CVW) due to its significant transformation from a traditional life insurer to a digitally-enabled, efficient platform. With a robust FY25 performance signaling a turning point, Clearview has shown operational improvements—such as reduced customer acquisition costs and enhanced profitability. The company's strategy emphasizes margin enhancement through targeted pricing and technological upgrades, which provide a competitive advantage in a rapidly evolving market. With a lean balance sheet and ongoing share buybacks, Clearview presents strong upside potential, trading at attractive valuation metrics amidst promising earnings growth. Its evolving profile supports a favorable investment outlook.

What is the short interest in Clearview Wealth Ltd (ASX:CVW)?

According to ASIC filings, there is negligible or no short interest in Clearview Wealth Ltd (ASX:CVW).

What does Clearview Wealth Ltd (ASX:CVW) do?

ClearView Wealth Ltd. is a non-operating holding company, which provides wealth management, life insurance, and integrated financial services. It operates through the Life Insurance and Wealth Management segments. The Life Insurance segment refers to ClearView Life Assurance Limited manufactures ClearView life insurance products under a retail life insurance Australian Financial Services license. The Wealth Management segment consists of ClearView Financial Management Limited, ClearView Life Nominees Pty Limited, and CLAL manufacture investment and retirement solutions under AFS licenses and a registrable superannuation entity trustee license. The company was founded by Simon Swanson in 1976 and is headquartered in Sydney, Australia.

faqs
q1
q2
q3
q4
q5

Newsletter Sign Up

Join the email list for updates.

Thesis-Tracker.com is Australia's largest professional investment commentary database. Thesis Tracker covers ASX listed companies with 5,000+ insights provided directly from financial services professionals. Thesis-Tracker.com does not enter into commercial arrangements with any of the featured financial services professionals nor publish proprietary opinions. Before making a decision please consider these and any relevant Product Disclosure Statement. Any advice on this site is general in nature and does not take into consideration your objectives, financial situation or needs.

bottom of page